INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Clinical trials for INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy aims to slow lung scarring in progressive fibrosis
Disease control Recruiting nowThis study tests an inhaled version of the drug pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their u…
Matched conditions: INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 26, 2026 05:24 UTC
-
New screening method aims to catch lung disease early in arthritis patients
Knowledge-focused Recruiting nowThis study is looking at 800 adults with rheumatoid arthritis to create a standard screening plan for lung complications. Researchers will use CT scans and AI to analyze risk factors and detect lung issues early. The goal is to improve monitoring and care for people with rheumato…
Matched conditions: INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Sponsor: Medical University Innsbruck • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC